相关实验视频
Updated: May 13, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
miR-126-5p通过RICTOR/AKT通路抑制HeLa和石川细胞的增殖和迁移
Xuan Zhang1, Yanjing Yang2, Yaqin Li1
1Department of Obstetrics, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, 050011, Hebei Province, China.
Discover oncology
|April 16, 2025
概括
微RNA-126-5p (miR-126-5p) 显著抑制子宫癌细胞的生长,并促进细胞死亡. 这种微RNA显示出作为改善子宫癌治疗结果的新型治疗点的希望.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 子宫癌的发病率和死亡率越来越高.
- 由于瘤异质性和耐药性,目前的治疗方法面临着挑战.
- 对于子宫癌,迫切需要新的治疗点.
研究的目的:
- 调查miR-126-5p在子宫癌发病过程中的作用.
- 评估miR-126-5p作为潜在的治疗点.
- 在子宫癌中探索miR-126-5p的分子机制.
主要方法:
- 使用了HeLa和石川细胞系.
- 评估了miR-126-5p对细胞增殖,迁移和细胞亡的影响.
- 研究了RICTOR/AKT信号通路的参与.
主要成果:
- miR-126-5p显著抑制了细胞的增殖和迁移.
- miR-126-5p显著促进了癌细胞的亡.
- 这些效应是由RICTOR/AKT信号通路介导的.
结论:
- miR-126-5p是子宫癌进展的关键调节剂.
- miR-126-5p代表了对子宫癌的有前途的治疗标.
- 这项研究支持开发基于miRNA的子宫癌治疗方法.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
MicroRNAs
21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K

